ARTIVION INC (AORT)       13.02  -0.27 (-2.03%)

13.02  -0.27 (-2.03%)

US2289031005 - Common Stock - After market: 13.02 0 (0%)

ARTIVION INC13.02

NYSE:AORT (12/6/2022, 7:21:33 PM)-0.27 (-2.03%)

After market: 13.02 0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-15 2023-02-15
Ins Owners 4.61% Inst Owners N/A
Market Cap 525.09M Shares 40.33M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 85
IPO 02-12 1993-02-12

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AORT Daily chart

Company Profile

Artivion, Inc. focuses on developing solutions that address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. The company is headquartered in Kennesaw, Georgia and currently employs 1,300 full-time employees. The company operates in two segments: Medical Devices and Preservation Services. The company has four product families: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC stent grafts and surgical products (collectively, JOTEC Products), the Ascyrus Medical Dissection Stent (AMDS) hybrid prosthesis, and the NEXUS endovascular stent graft system (NEXUS). Surgical sealants include BioGlue Surgical Adhesive (BioGlue) products. The company also sells or distributes PhotoFix bovine surgical patches, CardioGenesis cardiac laser therapy, Therion chorioamniotic allografts, and PerClot hemostatic powder.

Company Info

ARTIVION INC

1655 Roberts Boulevard N W

Kennesaw GEORGIA

P: 17704193355.0

Employees: 1300

Website: https://artivion.com/

AORT News

News Imagea month ago - Artivion, Inc.Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

News Image2 months ago - Artivion, Inc.Elizabeth Hoff Joins Artivion Board of Directors

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the appointment of...

News Image2 months ago - Artivion, Inc.Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial

/PRNewswire/ --- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has stopped the...

News Image3 months ago - Artivion, Inc.Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at...

News Image3 months ago - Artivion, Inc.Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

AORT Twits

Here you can normally see the latest stock twits on AORT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example